Allarity Therapeutics, Inc. (ALLR) has a negative trailing P/E of -1.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -68.52%.
Criteria proven by this page:
Overall SharesGrow Score: 23/100 with 0/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2017 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2018 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2019 | -46,515.5 | 0.00 | 36,809.64 | 5,548,132.62 | - |
| 2020 | -5,191.5 | -6.52 | 1,402.45 | 0.00 | - |
| 2021 | -2,475.6 | 25.96 | 3,512.00 | 0.00 | - |
| 2022 | -174.3 | 2.92 | 1,480.88 | 0.00 | - |
| 2023 | -92.2 | 1.14 | -398.69 | 0.00 | - |
| 2024 | -0.1 | 0.00 | 0.16 | 0.00 | - |
| 2025 | -1.4 | 0.01 | 1.58 | 48.53 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.00 | $143.28K | $-3.68M | -2570.4% |
| 2017 | $0.00 | $1.46M | $-4.9M | -335.7% |
| 2018 | $0.00 | $1.46M | $-2.29M | -157% |
| 2019 | $-189,613.00 | $120K | $-14.4M | -12000% |
| 2020 | $-1,698,640.00 | $0.00 | $-5.07M | - |
| 2021 | $-3,520,100.00 | $0.00 | $-26.65M | - |
| 2022 | $-1,856,060.00 | $0.00 | $-16.06M | - |
| 2023 | $-0.01 | $0.00 | $-11.9M | - |
| 2024 | $0.00 | $0.00 | $-24.52M | - |
| 2025 | $0.00 | $320K | $-11.23M | -3509.7% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.97 | $-0.97 – $-0.97 | $99.78M | $99.78M – $99.78M | 1 |
| 2027 | $-25.20 | $-25.20 – $-25.20 | $85.87M | $85.87M – $85.87M | 1 |
